These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8583877)

  • 21. Macromolecular intravenous contrast agent for MR lymphography: characterization and efficacy studies.
    Harika L; Weissleder R; Poss K; Papisov MI
    Radiology; 1996 Feb; 198(2):365-70. PubMed ID: 8596833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation using an HER-2/neu transgenic mouse model of a newly developed MR contrast agent with the effect of an antitumor drug.
    Sonoda A; Nitta N; Ohta S; Nitta-Seko A; Murata S; Jo J; Tabata Y; Takahashi M; Tani T; Murata K
    J Magn Reson Imaging; 2009 Oct; 30(4):907-10. PubMed ID: 19787744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioinspired, Manganese-Chelated Alginate-Polydopamine Nanomaterials for Efficient in Vivo T
    Addisu KD; Hailemeskel BZ; Mekuria SL; Andrgie AT; Lin YC; Tsai HC
    ACS Appl Mater Interfaces; 2018 Feb; 10(6):5147-5160. PubMed ID: 29277987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic changes induced by vasomodulators in kidneys, livers, muscles, and implanted tumors in rats as measured by dynamic Gd-DTPA-enhanced MRI.
    Su MY; Wang Z; Roth GM; Lao X; Samoszuk MK; Nalcioglu O
    Magn Reson Med; 1996 Dec; 36(6):868-77. PubMed ID: 8946352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanodiamond-Manganese dual mode MRI contrast agents for enhanced liver tumor detection.
    Hou W; Toh TB; Abdullah LN; Yvonne TWZ; Lee KJ; Guenther I; Chow EK
    Nanomedicine; 2017 Apr; 13(3):783-793. PubMed ID: 28003120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution and photodynamic effect of zinc phthalocyanine disulfonate in nude mice bearing mammary carcinoma.
    Mosa M; Zitko M; Poucková P
    Neoplasma; 1997; 44(3):178-83. PubMed ID: 9372860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Manganese-based Alternative to Gadolinium: Contrast-enhanced MR Angiography, Excretion, Pharmacokinetics, and Metabolism.
    Gale EM; Wey HY; Ramsay I; Yen YF; Sosnovik DE; Caravan P
    Radiology; 2018 Mar; 286(3):865-872. PubMed ID: 29117483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gadolinium-free T1 contrast agents for MRI: tunable pharmacokinetics of a new class of manganese porphyrins.
    Cheng HL; Haedicke IE; Cheng W; Tchouala Nofiele J; Zhang XA
    J Magn Reson Imaging; 2014 Dec; 40(6):1474-80. PubMed ID: 24214904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue relaxation enhancement after intravenous administration of (ITCB-DTPA)-gadolinum conjugated albumin, an intravascular magnetic resonance imaging contrast agent.
    Niemi P; Koskinen S; Reisto T
    Invest Radiol; 1991 Jul; 26(7):674-80. PubMed ID: 1885276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First in vivo MRI assessment of a self-assembled metallostar compound endowed with a remarkable high field relaxivity.
    Livramento JB; Weidensteiner C; Prata MI; Allegrini PR; Geraldes CF; Helm L; Kneuer R; Merbach AE; Santos AC; Schmidt P; Tóth E
    Contrast Media Mol Imaging; 2006; 1(1):30-9. PubMed ID: 17193598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of gadolinium 2,5-BPA-DO3A, a new macrocyclic hepatobiliary chelate, in normal liver and metastatic disease on high field magnetic resonance imaging.
    Runge VM; Wells JW; Williams NM
    Invest Radiol; 1996 Jan; 31(1):11-6. PubMed ID: 8850360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metalloporphyrin enhancement of magnetic resonance imaging of human tumor xenografts in nude mice.
    Furmanski P; Longley C
    Cancer Res; 1988 Aug; 48(16):4604-10. PubMed ID: 3396012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MRI tumor characterization using Gd-GlyMe-DOTA-perfluorooctyl-mannose-conjugate (Gadofluorine M), a protein-avid contrast agent.
    Raatschen HJ; Swain R; Shames DM; Fu Y; Boyd Z; Zierhut ML; Wendland MF; Misselwitz B; Weinmann HJ; Wolf KJ; Brasch RC
    Contrast Media Mol Imaging; 2006; 1(3):113-20. PubMed ID: 17193687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Magnetic resonance imaging of osteosarcoma using a bis(alendronate)-based bone-targeted contrast agent.
    Ge P; Sheng F; Jin Y; Tong L; Du L; Zhang L; Tian N; Li G
    Biomed Pharmacother; 2016 Dec; 84():423-429. PubMed ID: 27682736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of CH3-DTPA-Gd (NMS60) as a new MR contrast agent: early phase II study in brain tumors and dual dynamic contrast-enhanced imaging.
    Ito M; Ogino H; Oshima H; Shiraki N; Shibamoto Y; Kasai H; Mase M; Kawamura Y; Miyati T
    Magn Reson Imaging; 2006 Jun; 24(5):625-30. PubMed ID: 16735185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imaging Tumor Necrosis with Ferumoxytol.
    Aghighi M; Golovko D; Ansari C; Marina NM; Pisani L; Kurlander L; Klenk C; Bhaumik S; Wendland M; Daldrup-Link HE
    PLoS One; 2015; 10(11):e0142665. PubMed ID: 26569397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DCE-MRI using small-molecular and albumin-binding contrast agents in experimental carcinomas with different stromal content.
    Farace P; Merigo F; Fiorini S; Nicolato E; Tambalo S; Daducci A; Degrassi A; Sbarbati A; Rubello D; Marzola P
    Eur J Radiol; 2011 Apr; 78(1):52-9. PubMed ID: 19443159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamic contrast-enhanced MRI in mouse tumors at 11.7 T: comparison of three contrast agents with different molecular weights to assess the early effects of combretastatin A4.
    Fruytier AC; Magat J; Neveu MA; Karroum O; Bouzin C; Feron O; Jordan B; Cron GO; Gallez B
    NMR Biomed; 2014 Nov; 27(11):1403-12. PubMed ID: 25323069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Manganese-enhanced magnetic resonance imaging for early detection and characterization of breast cancers.
    Alhamami M; Bayat Mokhtari R; Ganesh T; Tchouala Nofiele J; Yeger H; Margaret Cheng HL
    Mol Imaging; 2014; 13():. PubMed ID: 25060340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: a new biodegradable MRI contrast agent.
    Wen X; Jackson EF; Price RE; Kim EE; Wu Q; Wallace S; Charnsangavej C; Gelovani JG; Li C
    Bioconjug Chem; 2004; 15(6):1408-15. PubMed ID: 15546209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.